DSIP 5MG
SKU: CP_DSIP_5MG_3ML_VIAL
Catalog price · 1 item: US$42.00 (USD)
Product information
Nonclinical research
The description discusses a 2021 rat middle-cerebral-artery-occlusion study with DSIP exposure spanning the pre-occlusion and reperfusion periods. Motor behavior was followed for 21 days and infarction volume was assessed at the endpoint. Rotarod performance recovered faster in treated rats, while the difference in infarction volume was not statistically significant. The findings are limited to that experimental stroke model.
Specifications
| SKU | CP_DSIP_5MG_3ML_VIAL |
|---|---|
| CATEGORY | Research Compounds |
| CAS | 62568-57-4 |
| VIAL SIZE | 3 mL |
| FORM | LYOPHILIZED POWDER |
| MOLECULAR WEIGHT | 848.82 g/mol |
| SEQUENCE | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu |
| MOLECULAR FORMULA | C35H48N10O15 |
| ITEM ID | 11681 |
| PURITY | 99%+ |
| CAS | 62568-57-4 |
| FORM | LYOPHILIZED POWDER |
| DOSAGE | 5 MG |